AI Article Synopsis
Article Abstract
Omalizumab,as a biological agent targeting IgE,is a recombinant humanized monoclonal antibody and the first targeted drug approved for treating moderate-to-severe bronchial asthma.By reviewing one case of aspirin-induced asthma complicated with nasosinusitis and otitis media,we discussed the value of omalizumab in the treatment of asthma and its complications,aiming to provide a reference for clinical practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3881/j.issn.1000-503X.15265 | DOI Listing |
Publication Analysis
Top Keywords
aspirin-induced asthma
8
asthma complicated
8
complicated nasosinusitis
8
nasosinusitis otitis
8
[omalizumab treats
4
treats aspirin-induced
4
otitis mediareport
4
mediareport case]
4
case] omalizumabas
4
omalizumabas biological
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!